- Prevalence of antibiotic use, course of treatment, adverse drug reaction, and abnormality in lab tests after antibiotic use among pregnant women (continuation) (N=125).
Characteristics | ADR occurred afteusing antibiotics? | Abnormality in lab tests afterusing antibiotics? | ||||
---|---|---|---|---|---|---|
Yes (%) | No (%) | P-value | Yes (%) | No (%) | P-value | |
Age† | ||||||
<18 years | 1 (0.8) | 0 | 0.257 | 0 | 1 (0.8) | 0.122 |
18-25 years | 12 (9.6) | 20 (16.0) | 0 | 32 (25.6) | ||
25-30 years | 12 (9.6) | 23 (18.4) | 5 (4.0) | 30 (24.0) | ||
30-35 years | 17 (13.6) | 32 (25.6) | 5 (4.0) | 44 (35.2) | ||
35-40 years | 5 (4.0) | 2 (1.6) | 0 | 7 (5.6) | ||
>40 years | 0 | 1 (0.8) | 0 | 1 (0.8) | ||
Nationality† | ||||||
Saudi | 31 (24.8) | 53 (42.4) | 0.774 | 7 (5.6) | 77 (61.6) | 0.626 |
Indian | 2 (1.6) | 2 (1.6) | 1 (0.8) | 3 (2.4) | ||
Yemeni | 4 (3.2) | 5 (4.0) | 0 | 9 (7.2) | ||
Egyptian | 4 (3.2) | 8 (6.4) | 2 (1.6) | 10 (8.0) | ||
Syrian | 0 | 1 (0.8) | 0 | 1 (0.8) | ||
Jordanian | 1 (0.8) | 3 (2.4) | 0 | 4 (3.2) | ||
Palestinian | 1 (0.8) | 0 | 0 | 1 (0.8) | ||
Sudanese | 4 (3.2) | 5 (4.0) | 0 | 9 (7.2) | ||
Others | 0 | 1 (0.8) | 0 | 1 (0.8) | ||
Body mass index† | ||||||
<18 | - | - | 0.046* | - | - | 0.401 |
18.5-25 | 17 (13.6) | 21 (16.8) | 5 (4.0) | 33 (26.4) | ||
25-30 | 23 (18.4) | 30 (24.0) | 3 (2.4) | 50 (40.0) | ||
Above 30 | 7 (5.6) | 27 (21.6) | 2 (1.6) | 32 (25.6) | ||
History of miscarriage§ | ||||||
Yes | 26 (20.8) | 32 (25.6) | 0.141 | 4 (3.2) | 54 (43.2) | 0.751 |
No | 21 (16.8) | 46 (36.8) | 6 (4.8) | 61 (48.8) | ||
Order of current pregnancy† | ||||||
First | 5 (4.0) | 11 (8.8) | 0.823 | 1 (0.8) | 15 (12.0) | 0.061 |
Second | 11 (8.8) | 22 (17.6) | 0 | 33 (26.4) | ||
Third | 9 (7.2) | 12 (9.6) | 2 (1.6) | 19 (15.2) | ||
Fourth | 9 (7.2) | 17 (13.6) | 5 (4.0) | 21 (16.8) | ||
Above fourth | 13 (10.4) | 16 (12.8) | 2 (1.6) | 27 (21.6) | ||
Weeks of current pregnancy† | ||||||
5-10 weeks | 9 (7.2) | 6 (4.8) | 0.230 | 0 | 15 (12.0) | 0.489 |
10-15 weeks | 7 (5.6) | 9 (7.2) | 1 (0.8) | 15 (12.0) | ||
15-20 weeks | 11 (8.8) | 13 (10.4) | 1 (0.8) | 23 (18.4) | ||
20-25 weeks | 7 (5.6) | 20 (16.0) | 3 (2.4) | 24 (19.2) | ||
25-30 weeks | 7 (5.6) | 14 (11.2) | 3 (2.4) | 18 (14.4) | ||
30-35 weeks | 6 (4.8) | 16 (12.8) | 2 (1.6) | 20 (16.0) | ||
Presence of other disease† | ||||||
Hypertension | 2 (1.6) | 0 | 0.099 | 0 | 2 (1.6) | 0.218 |
Gestational diabetes | 0 | 1 (0.8) | 0 | 1 (0.8) | ||
Asthma | 0 | 1 (0.8) | 0 | 1 (0.8) | ||
Inflammatory bowel disease | 1 (0.8) | 0 | 1 (0.8) | 0 | ||
No | 44 (35.2) | 76 (60.8) | 9 (7.2) | 111 (88.8) |